Proprietary Subzero Unfrozen (SU) cell storage for optimal cell viability and function.

CryoStasis’ revolutionary approach to preserving biological material traces its roots to the Canadian Arctic. Born of biochemist Olga Kukal’s fascination with the winter survival strategies of insects, our technology rejects a commonly held belief – that in order to preserve life, we must freeze it.

Our novel cold chain management process using a combination of media, temperature and pressure to preserve biological material indefinitely.

One formulation for short or long-term storage that leverages cold shock inhibitors and membrane protectants to prevent cryoinjury to cells.

Our devices and shipping solutions ensure viability and provide the flexibility to easily integrate into manufacturing and logistics.

Pressurization lowers the freezing point, and along with it, cell metabolism, thereby enabling long-term storage.

CryoStasis’ clinically proven technology makes it possible to go from production line to bedside with one formulation. Our serum-free, DMSO-free, chemically defined media and subzero unfrozen platform easily integrate into any manufacturing process.

Highlights from the ongoing collaboration between OHRI's BMC and CryoStasis presented at the 2024 Till & McCullouch Meeting

CryoStasis & UHN deliver compelling kidney transplant results for subzero unfrozen preservation technology

Exciting news in support of the CryoStasis mission

Describes the interdependency of corporate strategy and QMS

We’re on a mission to enable lifesaving research and improve patient outcomes around the world.